Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
Amed Co., Ltd., based in New Taipei City, Taiwan, operates as a developer, manufacturer, and distributor of medical equipment within the region. Established in 2008, the company offers a diverse portfolio of products. Its wound care segment features HERADERM-branded dressing products, along with Genadyne negative pressure wound therapy systems specifically engineered to deliver continuous 24-hour oxygen to wounds, and Natrox wound treatment systems. Beyond wound care, Amed's offerings also include Naldebain, a line of injections providing extended pain relief for up to seven days. Furthermore, the company provides POLYSITE pressure injectable implantable port kits and easyEndo universal linear cutting staplers.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.